Research Information
Acetaminophen May Be a Leading Cause of Acute Liver Failure
Alcohol, Diabetes and Hepatitis Boost Liver Cancer Risk
Alcohol and Hepatitis C
Epoetin alfa for the Treatment of Combination Therapy-Induced Hemolytic Anemia in Patients Infected With Hepatitis C Virus
Management of Anemia and Fatigue in an HIV-HCV-Coinfected Patient
Regular Testing Needed to Reduce Hemodialysis-Related HCV Infections
Hepatitis-Positive Livers Are Safe to Use in Hepatitis-Positive Transplant Recipients
Hepatitis A Vaccination Rates Low Among Patients With Chronic HCV Infection
CDC HCV Testing Flow Chart
CDC Phys. Interpertation of HCV test Results
Chronic Hepatitis C Presents Differently in End-Stage Renal Disease Patients
Hepatitis C Clearance Maintained Years After Successful Interferon Therapy
HALT-C: Quantitative liver function tests confirm improvement after SVR in HCV-infected patients
Clinical Utility of Viral Load Measurements in Individuals With Chronic Hepatitis C Infection on Antiviral Therapy
Current and Future Concepts in Hepatitis C Therapy
Diabetes Triples Risk of Liver Cancer
Drug Development Phases
Drug Trials, PhRMA Listings july 05
For HCV Genotype 2 or 3, 12 Weeks’ Treatment, Rather Than 24, May Suffice
Hepatitis and Normal LiverEnzymes--Role of Liver Histology
Hepatitis C Co-Infection Blunts HAART Immune Restoration in HIV
Hepatitis C in a Patient Being Evaluated for Kidney Transplantation?